Gilead Sciences and Arcus Biosciences, an oncology-focused biopharma working to create best-in-class cancer therapeutics, have entered into a ten-year partnership to co-develop and co-commercialise current and future therapeutic product...

Atomwise announces partnerships to tackle COVID-19

Atomwise, a San Fran company using AI for small molecule drug discovery, has announced it has fifteen research collaborations underway with leading global universities...

GSK secures additional biopharma capacity via Samsung Biologics partnership

GlaxoSmithKline (GSK) has secured additional manufacturing capacity for its biopharmaceutical portfolio by partnering with South Korea’s Samsung Biologics. As per the agreement, Samsung Biologics will...

Sinovac secures $15m to accelerate COVID-19 vaccine development

Sinovac Biotech, a Chinese biopharma product provider, has secured $15 million to accelerate the development of a COVID-19 vaccine. The funds were invested by Advantech...

View the Online Magazine

- Advertisement -

Launches

First generic remdesivir for COVID-19 treatment launched

Beximco Pharmaceuticals, the Bangladesh-based manufacturer of generic pharma products and APIs, has launched the world’s first generic remdesivir for treating COVID-19. Remdesivir is an antiviral...

Dyno launches to transform gene therapy using AI

Dyno Therapeutics, a Cambridge, Massachusetts-based biotech applying AI to gene therapy has officially launched from stealth mode with its proprietary platform, CapsidMap. The platform enables...

Bio-Rad launches anti-certolizumab pegol antibodies

Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of assays for therapeutic drug monitoring of tumor necrosis...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Demand for security of pharma & medical supplies post-COVID drives open standards

Demand from governments and health organisations for greater assurances on the integrity and reliability of pharmaceutical and medical products to treat COVID-19 has prompted...

Gilead’s suspension of China COVID-19 trials should serve as bellwether for studies in other countries – GlobalData

China trials of Gilead Sciences’ antiviral drug remdesivir in patients with mild symptoms of COVID-19 have been suspended due to lack of eligible patients. In...

Applied DNA ships COVID-19 vaccine candidates to begin animal testing

Applied DNA Sciences has shipped five COVID-19 vaccine candidates to Italy-based Takis Biotech, a developer of cancer vaccines and the company’s COVID-19 vaccine development...

In response to COVID-19, ACG takes measures to ensure workforce & public health

As a key pharma supply player, ACG is committed to working with its partners to ‘make the world healthier’. This means that of primary...

Approvals

Tecentriq gains first-line approval in NSCLC

The FDA has approved Roche’s Tecentriq (atezolizumab) as a first-line monotherapy for the treatment of metastatic non-small cell lung cancer (NSCLC), marking its fourth...

European approval for gene therapy to treat SMA

European regulators have granted conditional approval to Novartis company AveXis for the gene therapy Zolgensma (onasemnogene abeparvovec) for the treatment of paediatric patients with...

Breakthrough status for Enhertu in NSCLC

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of patients with metastatic...

FDA fast-tracks Moderna’s mRNA vaccine against coronavirus

The FDA has fast-tracked Moderna’s mRNA vaccine candidate (mRNA-1273) against the novel coronavirus (SARS-CoV-2). “Fast Track designation underscores the urgent need for a vaccine against...

New drug approvals in US down 16% in 2019 – GlobalData

In 2019, the US Food and Drug Administration (FDA) accepted 119 New Drug Approvals (NDAs) and Biologics License Applications (BLAs) including New Molecular Entities...

Japan approves remdesivir for COVID-19 patients

Veklury (remdesivir) has been approved in Japan as a treatment for COVID-19 under an exceptional approval pathway, Gilead has announced. The exceptional approval was granted...

Manufacturiung

Finance

Sinovac secures $15m to accelerate COVID-19 vaccine development

Sinovac Biotech, a Chinese biopharma product provider, has secured $15 million to accelerate the development of a COVID-19 vaccine. The funds were invested by Advantech...

CytoAgents secures NIH grant to accelerate treatment for cytokine storm

CytoAgents, a Pittsburgh-based biotech focussed on viral infectious diseases, has secured a £1.6 million grant from the National Institutes of Health (NIH) to accelerate...

AstraZeneca gains global rights to brazikumab from Allergan

AstraZeneca has completed its recovery of the global rights to brazikumab (formerly MEDI2070), a monoclonal antibody targeting IL23, from Allergan. AstraZeneca and Allergan have terminated...

CEPI invest further funds in Novavax for COVID-19 vaccine

The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $388 million of additional funding in next-gen vaccine maker, Novavax, to fund the...

Research & Development
Latest

Gilead & Arcus partner to develop next-gen cancer immunotherapies

Gilead Sciences and Arcus Biosciences, an oncology-focused biopharma working to create best-in-class cancer therapeutics, have entered into a ten-year partnership to co-develop and co-commercialise...

Vividion Therapeutics partners with Roche on novel E3 ligases

San Diego biotech, Vividion Therapeutics, is collaborating with Roche to leverage its proteomics screening platform and proprietary small molecule library to target novel E3...

Inovio publishes positive data on COVID-19 DNA vaccine

Inovio has published preclinical study data for IN0-4800 –  its COVID-19 DNA vaccine – demonstrating robust neutralising antibody and T cell immune responses against...

mRNA-based vaccine tech emerging as frontrunner against COVID-19

Messenger RNA (mRNA) based vaccine technology is emerging as one of the frontrunners among the technologies being evaluated to develop a vaccine for COVID-19,...

Antibody inhibits in vito COVID-19 infection in preclinical studies

Sorrento Therapeutics’s anti-SARS-CoV-2 antibody – STI-1499 – demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very...

Appointments

Senior promotions for PTC Therapeutics

New Jersey’s PTC Therapeutics has made a double senior appointment. Matthew Klein has been promoted to Chief Development Officer and Eric Pauwels to Chief Business...

Immune Regulation appoints new CEO

Jonathan Rigby has been appointed CEO of Immune Regulation, a London-based clinical stage biotech focussed on for inflammatory and immunological diseases. Based in the US,...

Jazz appoints industry veteran amid expansion

Jazz Pharmaceuticals has appointed industry veteran Samantha Pearce as its Senior Vice President of Europe/Rest of World. Before joining the the Dublin-headquartered biopharma, Ms Pearce...
- Advertisement -

FDA fast-tracks Moderna’s mRNA vaccine against coronavirus

The FDA has fast-tracked Moderna’s mRNA vaccine candidate (mRNA-1273) against the novel coronavirus (SARS-CoV-2). “Fast Track designation underscores the urgent need for a vaccine against...

New drug approvals in US down 16% in 2019 – GlobalData

In 2019, the US Food and Drug Administration (FDA) accepted 119 New Drug Approvals (NDAs) and Biologics License Applications (BLAs) including New Molecular Entities...